Tapan K. Bera

Biography

Dr. Bera received his M.S. and Ph.D. in biochemistry from the Calcutta University, India. His research objectives include understanding the molecular basis of cancer by identifying the genes involved in this process and translating this information for possible targeted therapy of cancer. His recent studies focus on the development of recombinant Fab-immunotoxin targeting lymphoma and multiple myeloma. Dr. Bera has generated several genetically modified mouse models to evaluate the function of cancer-associated genes as well as for preclinical evaluation of recombinant immunotoxin-targeting mesothelin. Dr. Bera received his M.S. and Ph.D. in biochemistry from the Calcutta University, India. He completed his postdoctoral training at the Cancer Research Laboratory, University of California-Berkeley and at the Laboratory of Molecular Biology, Center for Cancer Research, NCI. Currently, Dr. Bera is an associate scientist.

Research Interest

1) antibody engineering, 2) immunotherapy, 3) recombinant immunotoxin, 4) multiple myeloma, 5) BCMA, 6) mesothelin, 7) Cancer Biology, 8) Genetics and Genomics, 9) Molecular Biology and Biochemistry